Kimberly-Clark Corporation
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Michael D. Hsu
- Full Time Employees
- 36,000
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- PO Box 619100 Dallas TX United States of America 75261-9100
- IPO Date
- Mar 17, 1980
- CIK
- 0000055785
- Website
- kimberly-clark.com
- Similar Companies
- Business
- Kimberly-Clark Corporation manufactures and markets a broad range of personal care, consumer tissue, and professional products made from natural or synthetic fibers, utilizing technologies in fibers, nonwovens, and absorbency; its core offerings span personal care products including Huggies disposable diapers and baby wipes, Pull-Ups training pants, GoodNites bedwetting products, Kotex feminine hygiene pads, pantiliners and tampons, Poise and Depend incontinence pads, briefs and liners; consumer tissue brands such as Kleenex facial tissues, Scott, Cottonelle and Andrex toilet papers and bathroom tissues, Viva and Scott paper towels; and professional lines like WypAll utility wipes and cleaning cloths, KimWipes scientific wipes, plus soaps, sanitizers and workplace hygiene solutions under Kimberly-Clark Professional. Founded in 1872 in Neenah, Wisconsin, and headquartered in Irving, Texas, the company operates globally in more than 175 countries, serving consumers, retailers, businesses, institutions and healthcare providers through three main segments: Personal Care, Consumer Domestic and International Family Care and Professional, with manufacturing facilities across North America, Europe, Latin America and Asia. Kimberly-Clark employs approximately 40,000 people worldwide and generates annual revenues exceeding $18 billion. In recent developments, Kimberly-Clark announced in June 2025 a strategic partnership with Suzano S.A., under which it contributes substantially all assets of its International Family Care and Professional business—generating $3.3 billion in 2024 net sales across more than 70 countries, 22 facilities and 9,000 employees—for a 49% stake in a new joint venture valued at $3.4 billion, with the deal expected to close in mid-2026 and excluding its interests in Mexico and South Korea. The company is also pursuing the $48.7 billion acquisition of Kenvue Inc., announced in November 2025, which would integrate iconic brands like Tylenol, Band-Aid, Neutrogena, Aveeno, Listerine, Benadryl and Johnson's Baby into its portfolio, creating a $32 billion global health and wellness leader with projected synergies of $2.1 billion. Complementing these moves, Kimberly-Clark committed over $2 billion through 2030 to expand North American manufacturing—including a new facility in Warren, Ohio, and upgrades in Beech Island, South Carolina, plus a $130 million production line addition in Mobile, Alabama—aimed at boosting capacity for Huggies, Kleenex, Depend, Scott and Cottonelle amid rising demand, while advancing supply chain automation and innovation as part of its broadest transformation in 150 years.
Company News
Kimberly-Clark's 54-Year Dividend Streak Faces Its Biggest Test Yet With $48.7 Billion Kenvue Deal
My Favorite Consumer Staples Play Right Now
Kimberly Clark is Down 20% From Its 52-Week High. Is the Dip Worth Buying?
Can Kimberly-Clark's North America Business Accelerate in Second Half?
Kimberly-Clark Corporation (KMB) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Kenvue's Kimberly-Clark Deal Nears Closing With Key Risks Still Ahead
Baypointe Partners LLC Sells 90,000 Shares of Kimberly-Clark Corporation $KMB
Huggies® Rallies Communities to Recognize the Fighting Spirit of NICU Babies During NICU Awareness Month
Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment
Kimberly-Clark to Webcast its Presentation at Barclays 19th Annual Global Consumer Staples Conference
Can Kimberly-Clark's Innovation Pipeline Power Its Next Growth Phase?
4 Battle-Tested Consumer Staples Stocks That Keep Raising Their Dividends
Down 15% in One Year, Is Kimberly Clark an Undervalued Dividend Stock to Buy Right Now?
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal
Can Kimberly-Clark's Productivity Offset Inflationary Pressures?
How Much Do You Need Invested by 55 to Retire on Dividends at 65?
How Much Do You Need Invested to Out-Earn the Average American Household Income With Dividends?
5 Blue-Chip Dividend Stocks to Buy Before August Ends
Callan Family Office LLC Makes New Investment in Kimberly-Clark Corporation $KMB
How to Build $8,200 a Month in Dividend Income (And the Tax Bill Almost Nobody Plans For)